Bodyport, a company building sensitive sensor technologies into a bathroom scale, secured an $11.2 million Series A round to develop a device that can help detect and manage heart disease by detecting cardiac signals and biomarkers through bare feet. Boehringer Ingelheim Venture Fund (BIVF) led the round in the San Francisco-based startup, adding its capital […]